Global Oncology Biosimilars Market 2014-2018 - Industry Trends, Size, Share, Growth & Development

Submitted by: Submitted by

Views: 106

Words: 885

Pages: 4

Category: Business and Industry

Date Submitted: 11/21/2014 10:38 AM

Report This Essay

Global Oncology Biosimilars Market 2014-2018

Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they are not an exact copy of the reference biopharmaceutical product. Currently, biosimilars are being incorporated into oncology treatment practices. The biosimilars used in oncology in the supportive care setting are known as oncology biosimilars.

Browse Complete Report with TOC: http://www.marketresearchstore.com/report/global-oncology-biosimilars-market-2014-2018-1557

TechNavio's analysts forecast the Global Oncology Biosimilars market to grow at a CAGR of 29.87 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Oncology Biosimilars market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales biosimilars used in cancer treatment.

TechNavio's report, Global Oncology Biosimilars Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Oncology Biosimilars market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Buy this Report: http://www.marketresearchstore.com/checkout/reportId/1557/reportType/0

Key Regions

Americas

APAC

EMEA

Key Vendors

Biocon

Celltrion

Dr. Reddy's Laboratories

Hospira

Mylan

Sandoz

Other Prominent Vendors

3SBio

Abbvie

AstraZeneca

BioXpress Therapeutics

Boehringer Ingelheim

Coherus Biosciences

Intas Pharmaceuticals

Merck Serono

Pfizer

Wockhardt

Market Driver...